![]() |
Volumn 50, Issue 10, 2000, Pages 801-807
|
Expression of cytokeratin 1, 5, 14, 19 and transforming growth factors-β1, β2, β3 in osteofibrous dysplasia and adamantinoma: A possible association of transforming growth factor-β with basal cell phenotype promotion
|
Author keywords
Adamantinoma; Cytokeratin; Osteofibrous dysplasia; Transforming growth factor
|
Indexed keywords
CYTOKERATIN;
CYTOKERATIN 1;
CYTOKERATIN 14;
CYTOKERATIN 19;
CYTOKERATIN 5;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA1;
TRANSFORMING GROWTH FACTOR BETA2;
TRANSFORMING GROWTH FACTOR BETA3;
UNCLASSIFIED DRUG;
ADOLESCENT;
ADULT;
AMELOBLASTOMA;
ARTICLE;
CHILD;
CLINICAL ARTICLE;
FEMALE;
FIBROUS DYSPLASIA;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
IMMUNOMODULATION;
MALE;
PATHOGENESIS;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
ADOLESCENT;
ADULT;
BONE NEOPLASMS;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
FIBROUS DYSPLASIA, MONOSTOTIC;
FIBULA;
HUMANS;
IMMUNOENZYME TECHNIQUES;
KERATINS;
MALE;
MIDDLE AGED;
NEOPLASMS, GLANDULAR AND EPITHELIAL;
PHENOTYPE;
TIBIA;
TRANSFORMING GROWTH FACTOR BETA;
|
EID: 0033694920
PISSN: 13205463
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1440-1827.2000.01114.x Document Type: Article |
Times cited : (27)
|
References (33)
|